Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP789169.RAlGfHzVeioxgELY0c8PFvswwuBXgN840mfb6YCjt_S_s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP789169.RAlGfHzVeioxgELY0c8PFvswwuBXgN840mfb6YCjt_S_s130_assertion type Assertion NP789169.RAlGfHzVeioxgELY0c8PFvswwuBXgN840mfb6YCjt_S_s130_head.
- NP789169.RAlGfHzVeioxgELY0c8PFvswwuBXgN840mfb6YCjt_S_s130_assertion description "[CCN1, also known as CYR61, is a survival and proangiogenic factor overexpressed in about 30% of invasive breast carcinomas, and particularly in triple-negative breast carcinomas (TNBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789169.RAlGfHzVeioxgELY0c8PFvswwuBXgN840mfb6YCjt_S_s130_provenance.
- NP789169.RAlGfHzVeioxgELY0c8PFvswwuBXgN840mfb6YCjt_S_s130_assertion evidence source_evidence_literature NP789169.RAlGfHzVeioxgELY0c8PFvswwuBXgN840mfb6YCjt_S_s130_provenance.
- NP789169.RAlGfHzVeioxgELY0c8PFvswwuBXgN840mfb6YCjt_S_s130_assertion SIO_000772 21393426 NP789169.RAlGfHzVeioxgELY0c8PFvswwuBXgN840mfb6YCjt_S_s130_provenance.
- NP789169.RAlGfHzVeioxgELY0c8PFvswwuBXgN840mfb6YCjt_S_s130_assertion wasDerivedFrom befree-20140225 NP789169.RAlGfHzVeioxgELY0c8PFvswwuBXgN840mfb6YCjt_S_s130_provenance.
- NP789169.RAlGfHzVeioxgELY0c8PFvswwuBXgN840mfb6YCjt_S_s130_assertion wasGeneratedBy ECO_0000203 NP789169.RAlGfHzVeioxgELY0c8PFvswwuBXgN840mfb6YCjt_S_s130_provenance.